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The brain is particularly vulnerable to oxygen free radicals,
and these radicals have been implicated in the pathology of
several neurological disorders. In this study, the modulation of
TNF-related apoptosis-inducing ligand (TRAIL) expression by
oxidative stress was shown in LN215 cells, an astroglioma cell
line. Hydrogen peroxide (H2O2) treatment increased TRAIL
expression in LN215 cells and H2O2-induced TRAIL aug-
mented apoptosis in Peer cells, a cell line sensitive to TRAIL-
mediated cell death. Our findings suggest that the upregulation
of TRAIL in astroglial cells may abrogate immune cell effector
functions.
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INTRODUCTION
TNF-related apoptosis-inducing ligand (TRAIL),
a member of death ligand/receptor pairs, acts
independently of Fas-mediated apoptosis. Like
FasL, TRAIL induces rapid apoptosis in trans-
formed cell lines of diverse origins.
1,2 Death
receptors (DR) 4 and DR5, which are receptors for
TRAIL, mediate apoptosis by recruiting Fas-asso-
ciated death domain (FADD) indirectly via the
TNF receptor-associated death domain (TRADD)
and by the subsequent activation of capsase 8.
3,4
TRAIL and DR4 are expressed in many human
tissues, including the spleen, lung, and prostate.
5
The human TRAIL promoter was cloned, and a
number of transcription factor binding sites were
identified, namely, the NFAT, AP-1, and Sp1
sequences, which are important for the expression
of other TNF family members.
6 DR4 and DR5
were expressed in normal brain tissue and
glioma.
7 Although TRAIL expression is detected
in many human tissues, TRAIL is not always cyto-
toxic due to the presence of decoy receptors. The
decoy receptors, DcR1 and DcR2, have also been
found in many types of normal cells. whereas
many tumor cell lines do not express DcR1,
2,5
which abrogates apoptotic signals by binding
TRAIL, because DcR1 does not have death do-
mains. DcR2 has a truncated form of cytoplasmic
tail, which cannot transduce cell death signals.
8
The relationship between reactive oxygen inter-
mediate (ROIs) products and central nervous
system (CNS) tumors is a current and important
topic in light of their involvement in pathological
conditions and possible therapeutic interventions.
Hydrogen peroxide (H2O2) has been implicated in
cellular and tissue injury during pathologic con-
ditions, such as ischemia-reperfusion injury,
hyperoxia, and inflammation.
9 In addition, the
stimulation of various cells with either cytokines
or phorbol ester increases the secretion of H2O2
into the extracellular space in vitro.
10,11 High con-
centrations of this diffusible ROI exert toxic effects
on susceptible cells. However, low concentrations
Hydrogen Peroxide Upregulates TNF-Related Apoptosis-
Inducing Ligand (TRAIL) Expression in Human Astroglial
Cells, and Augments Apoptosis of T Cells
Daeho Kwon
1 and In-Hong Choi
2
1Department of Microbiology, Ajou University School of Medicine, Seoul, Korea;
2Department of Microbiology, Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine,
Seoul, Korea.
Received January 17, 2006
Accepted February 20, 2006
This work was supported by a research grant from KOSEF
(RO1-2002-000-00210-0) and also by KOSEF, through the Natio-
nal Core Research Center for Nanomedical Technology (R15-2004-
024-00000-0).
Reprint address: requests to Dr. In-Hong Choi, Department of
Microbiology, Yonsei University College of Medicine, 134 Shinchon-
dong, Seodaemum-gu, Seoul 120-752, Korea. Tel: 82-2-2228-1821,
Fax: 82-2-392-7088, E-mail: inhong@yumc.yonsei.ac.krDaeho Kwon and In-Hong Choi
Yonsei Med J Vol. 47, No. 4, 2006
of H2O2 alter cellular functions by modulating
signal transduction in certain cells, including
endothelial cells.
12 Oxidative injury occurs in vari-
ous ways and has been studied in several diverse
models, using different eliciting agents and biolo-
gical preparations. The common feature of these
models is that the primary activation involves
radical formation; those radicals and related pro-
ducts then generate a potent oxidant, which sub-
sequently inactivates macromolecules. ROI-medi-
ated damage has been generally associated with
necrosis; however, some observations suggest that
it has a role in apoptosis.
13 Recent observations
show that ROIs modulate the expression of Fas
and FasL. The expression of Fas was upregulated
in human endothelial cells under oxidative
stress,
14 and the upregulation of FasL has been




17,18 under conditions of oxidative
stress.
In order to address the effects of oxidative stress
in the brain, this study investigated the expression
levels of TRAIL in human astroglial cells after
H2O2 treatment.
MATERIALS AND METHODS
Culture of human astroglial cells and their treat-
ment with H2O2 or cyclosporin A
LN215, an astroglioma cell line, was cultured in
10% FCS (Gibco BRL, Grand Island, NY, USA)-
DMEM (Gibco BRL) containing 1% nonessential
amino acids (Sigma Chemicals Co., St. Louis, MO,
USA). The LN215 cell line was kindly provided by
Dr. E. G. Van Meir (Department of Neurosurgery,
Laboratory of Tumor Biology and Genetics, Lau-
sanne, Switzerland). The cells were incubated
with 200, 400, 600, and 800 M of H μ 2O2 (Sigma) for
various times (1-24 hrs). Cyclosporin A (CsA,
Sandoz, stock solution 50 mg/mL in DMSO) was
added at the conc. of 10, 100 ng, 1, 5, and 10 g μ
for 30 min before adding H2O2.
Isolation of total RNA and the synthesis of
cDNA
1 × 10
6 cells were cultured in a 75 cm
2 flask and
washed twice with PBS. H2O2 was added in serum
free RPMI medium. Total RNA was isolated with
an RNeasy kit (Qiagen, Santa Claris, CA, USA)
and 5 g of this RNA was used to synthesize cDNA μ
with 0.1 O.D. of random hexamer (Pharmacia,
Uppsala, Sweden) and 200 U of M-MLV reverse
transcriptase (Gibco BRL). The cDNA produced
was kept at -20 until used.
RT-PCR and RNase protection assay (RPA)
RT-PCR was performed using the following
primer sets: TRAIL primers (forward: 5'-CCC
AAT gAC gAA gAg AgT ATg A -3'; reverse:
5'-ggA ATA gAT gTA gTA AAA CCC T-3. PCR
conditions were as follows: denaturation at 94
for 30s, annealing at 55 for 30s, and extension
at 72 for 30s for TRAIL. The buffer used for PCR
was 10 mM Tris-HCl (pH 10), 2.0 mM MgCl2, 50
mM KCl with 1.25 U of Taq polymerase (Takara,
Tokyo, Japan). After 27 cycles, an additional ex-
tension at 72 for 10 min was carried out.
To detect TRAIL expressions, an RNase protec-
tion assay was done using the RiboQuant multi-
probe RNase protection assay system (Pharmingen,
San Diego, CA, USA). Briefly, 15 g of total RNA μ
was hybridized overnight with the in vitro-trans-
lated
32P-labeled RNA probe; hAPO-3C kit and
samples were treated with RNase A and pro-
teinase.
Western blot
A total of 1 × 10
6 LN215 cells were used for
protein purification. Protein was extracted by
ultrasonication and centrifuged to remove cell
debris. The resulting supernatant was quantified
using the Bradford method (Pierce, Rockford, IL,
USA). Protein (50 g) was then loaded onto 12% μ
Tris-HCL SDS-polyacrylamide gel (BioRad, Her-
cules, CA, USA), and transferred to a nitrocellu-
lose transfer membrane (Amersham Pharmacia
Biotech, Piscataway, NJ, USA). TRAIL expression
was determined using anti-TRAIL monoclonal Ab
(Pharmingen) diluted 1:500 and anti-mouse rabbit
Ab (Jackson Immuno Research, Baltimore, MD,
USA) was used as a secondary Ab. Proteins were
visualized using the ECL technique (Amersham
Pharmacia Biotech.).Enhancement of TRAIL-induced Cell Death by H2O2 in Human Astroglial Cells
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Flow cytometry analysis
Astroglial cells (2 × 10
5 cells/well) were plated
in six-well (35-mm
2) plates (Costar, Cambridge,
MA, USA) and grown to 90% confluency. For
analysis of TRAIL protein expression, cells were
trypsinized, suspended in PBS containing 5% fetal
bovine serum and 0.02% azide, incubated with
PE-conjugated anti-human TRAIL antibody
(Pharmingen), washed twice, fixed in 1% para-
formaldehyde, and then analyzed with FACStar/
(Becton Dickinson, Mountain View, CA, USA).
Negative controls were incubated with goat anti-
mouse IgG antibody conjugated to PE. Ten thou-
sand cells were analyzed for each sample.
Detection of cell death by staining of annexin-V
and PI
To study the expression of functional TRAIL in
astroglial cells, 2 × 10
5 LN215 cells were pre-
treated with 800 M of H μ 2O2 for 18 h in serum free
medium. Astroglial cells were washed to remove
H2O2 and reacted with Peer cells, which were
sensitive to TRAIL,
19 for 24 hrs. Effector cells (LN
215 cells) and target cells (Peer cells) were then
co-cultured at a ratio of 4 : 1. Cell death was mea-
sured by staining with annexin V and PI. Control
LN215 cells were cultured for 18 hrs in serum-free
media without H2O2. Annexin V-FITC and PI
(Trevigen, Gaithersburg, MD, USA) were used to
detection of cell death.
RESULTS
The expression of TRAIL in human astroglial
cells treated with H2O2
We hypothesized treatment with H2O2 would
modulate the apoptosis-related gene expression of
astroglial cells in central nerve system. To address
this, human LN215 astroglioma cells were treated
with H2O2 and the expression of TRAIL was
detected by RT-PCR, RPA, western blot and flow
cytometry.
We experimented to determine whether treat-
ment with H2O2 induced TRAIL expression in
human astroglial cells. LN215 cells were treated
with varying concentrations of H2O2 (0-800 M) μ
for 4 hrs (for mRNA) or 18 hrs (for protein). H2O2-
mediated TRAIL induction was observed by RT-
PCR (Fig. 1A) and western blot (Fig 2A). TRAIL
expression was induced treatment of H2O2 and
reached maximum expression at 800 M of H μ 2O2
(Fig. 1A, 2A). LN215 cells were treated with 800
M of H μ 2O2 for various times (0 - 24 hrs). The time
course of the TRAIL expression was then deter-
mined by RPA (Fig. 1B) or western blot (Fig 2C).
The gene expression of TRAIL was induced at 1
h and continued until 24 hrs (Fig. 1B). TRAIL pro-
tein expression reached its maximum at 8 hrs and
continued until 24 hrs (Fig. 2C). Also H2O2-media-
ted TRAIL induction was observed by flow
cytometry (Fig. 2B).
Inhibition of TRAIL expression by cyclosporin A
in human astroglial cells treated with H2O2
Cyclosporin A (CsA), an immunosuppressive
drug that targets calcineurin, blocked both RNA
and protein expression of TRAIL in LN215 cells
after treatment with H2O2 (Fig. 3A, 3B). The most
effective concentration of CsA started at 100 ng/
mL.
Fig. 1. Gene expression of TRAIL in human astroglial cells
after treatment with hydrogen peroxide (H2O2) in a dose
or time-dependent manner. (A) LN215 cells were treated
with varying doses of hydrogen peroxide (0 to 800 M) μ
for 4 hrs. (B) LN215 cells were incubated with hydrogen
peroxide 800 M for various times (0 to 24 μ hrs). Total
RNA was measured for TRAIL mRNA by RT-PCR (A) or
RNase protection assay (B). Cells not treated with H2O2
were used as control (CNTL). The data are representative
of three experiments.
A
BDaeho Kwon and In-Hong Choi
Yonsei Med J Vol. 47, No. 4, 2006
Fig. 3. Inhibition of TRAIL expression by cyclosporin A
(CsA) in human astroglial cells after treatment with H2O2.
(A) LN215 cells were pre-incubated with CsA (0.01 to 10
M) for 30 min, were treated with hydrogen peroxide (800 μ
M) for 4 μ hrs and then gene expression of TRAIL were
measured by RT-PCR. Cells not treated with H2O2 were
used as a control. -actin was used as the internal control. β
The fold induction was calculated as follows: (TRAIL/ - β
actin intensity in the study group)/(TRAIL/ -actin inten β -
sity in the control group). The fold induction value repre-
sents mean ± SD of triplicate experiments. (B) LN215 cells
were pre-incubated with CsA (1 M) for 30 min, were μ
treated with hydrogen peroxide (800 M) for 18 hrs and μ
then expression of TRAIL were measured by western blot.
The data are representative of three independent experi-
ments.
Fig. 2. Expression of TRAIL in human astroglial cells after
treatment with H2O2 in a dose or time-dependent manner.
(A) LN215 cells were treated with varying doses of
hydrogen peroxide (0 to 800 M) for 18 μ hrs. (C) LN215
cells were incubated with hydrogen peroxide 800 M for μ
various times (0 to 24 hrs). For western blot, 20 g of total μ
protein was loaded in 12% gel and anti-TRAIL mono-
clonal Ab was used as a primary Ab. (B) FACS analysis
of TRAIL expression on LN215 were treated with 800 M μ
of hydrogen peroxide for 18 hrs. The data are represen-
tative of three independent experiments.
Fig. 4. Induction of apoptosis in Peer cells by human astroglial cells treated with H2O2. LN215 cells were incubated with
800 M of H μ 2O2 for 18 hrs in serum free medium. LN215 cells were washed to remove H2O2 and then co-cultured with
Peer cells for 24 hrs. Effector cells (LN215 cells) and target cells (Peer cells) were co-cultured at a ratio of 4 : 1. Cell death
was measured by staining with annexin V. Control LN215 cells were not treated with H2O2, but maintained in serum free
condition for 18 hrs. LN215 were pre-incubated for 30 min with CsA (1 g/mL), and incubated with H μ 2O2. The fold
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The induction of the apoptosis of Peer cells by
human astroglial cells treated with H2O2
To address the biological function of TRAIL in
LN215 cells after H2O2 treatment, LN215 cells
were co-cultured with Peer cells, a cell line sensi-
tive to TRAIL mediated apoptosis. Annexin V
staining of Peer cells showed an increase in
apoptotic cells after H2O2 treatment, 64.2% versus
47.5% in the control group (Fig. 4). Peer cells
treated with both CsA and H2O2 inhibited TRAIL
induced apoptosis down to 49.8%, a level similar
to control (Fig. 4).
DISCUSSION
Our study demonstrates that oxidative stress
modulates the expression of TRAIL, which is in-
volved in apoptosis. The up-regulation of FasL
and Fas by IFN- or TNF- has been reported in γ α
primary astrocytes,
20 and H2O2 increased Fas and
FasL expression in astroglioma cell lines.
18 Al-
though Furuke et al. reported that H2O2 inhibits
CD16-induced FasL expression
21 and that reactive
oxygen species (ROS) suppress events upstream of
FasL expression, another report suggested that
oxidative stress induces FasL expression in hepa-
toma and microglial cells.
15,16 In other cell types,
H2O2 may induce FasL expression by activating
NF- B; H κ 2O2 is known to be a potent activator of
NF- B. Moreover, the CD95L promoter has been κ
described to contain NF- B binding sites, which κ
suggests that NF- B may regulate FasL expres κ sion.
In contrast to the limited expression of FasL,
TRAIL mRNA has been detected in nearly all
tissues. However, malignant astoroglioma cells
express both TRAIL mRNA and protein.
22,23 In our
study, TRAIL was detected constitutively in LN
215 cells, an astroglioma cell line, and its expres-
sion was increased by H2O2.
In this study, CsA, a pharmacological inhibitor
of the phosphatase calcineurin, blocked TRAIL
expression at concentrations between 100 and 10
g/mL. These concentrations are reported to be μ
nontoxic to primary rat astrocytes,
24 suggesting
that NFAT might be involved in TRAIL ex-
pression in human astrocytes. NFAT is known to
be expressed in T cells and other immune cells.
However, several data show that cells of the ner-
vous system, such as a neuronal cell line and rat
astrocytes, express NFAT.
24,25 Moreover, the CsA-
sensitive signaling pathway has been reported to
regulate the survival of reactive astrocytes.
24
Involvement of ROS in NFAT has been demon-
strated in T cells.
27,28 Also, 1.6 kb of the human
TRAIL promoter was identified to have binding
sites for such factors as NFAT, AP-1, and Sp1.
6
Therefore, NFAT, under conditions of oxidative
stress, may act as a transcription factor, signaling
induction of TRAIL. Although H2O2 has been
known to activate NF- B, κ
29,30 it is not certain
whether the expression of TRAIL and its receptors
is regulated by H2O2-activated NF- B. Although κ
basal ROI in tumors can be lower than in normal
brain tissue,
31 it is important to keep in mind the
effects of drug-induced apoptosis on tumor cells
by ROI-producing chemotherapies.
32
In our study, the upregulation of TRAIL sug-
gests that some astroglial cells up-regulate TRAIL
and may abrogate lymphocytes or other immune
cells, thereby escaping immune surveillance. Fur-
ther investigations into the regulation of TRAIL
and TRAIL receptors are necessary to answer
critical questions related to whether a specific gain
of decoy receptors and death receptors in as-
troglioma cells, as compared with non-neoplastic
cells allows the selective therapeutic elimination
of tumor cells in vivo.
Collectively our findings suggest that TRAIL
may be inducible by hypoxia and other forms of
oxidative stress, such as tumor-associated hypoxia
or chemotherapy-induced hypoxia. Therefore,
oxidative stress leading to the upregulation of
TRAIL presumably plays an apoptotic role in
pathological conditions of the brain.
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